Why is Kimberly-Clark buying Tylenol maker Kenvue?
How will OpenAI’s $38B Amazon deal impact AI growth?
What caused the YouTube TV-Disney blackout?
How did Trump’s tariffs affect global manufacturing?
Why are SNAP benefits partially funded during shutdown?
What drives Palantir’s recent revenue surge?
How is AI reshaping corporate layoffs and hiring?
BridgeBio's genetic muscle disorder drug meets all goals in late-stage trial
reuters.com/business/healthcare-pharmaceuticals/bridgebios-genetic-muscle-disorder-drug-meets-all-goals-late-stage-trial-2025-10-27
This story appeared on reuters.com, 2025-10-27 11:05:58.322000.